Skip to main content

Advertisement

Log in

Reversal of visual attention dysfunction after AMPA lesions of the nucleus basalis magnocellularis (NBM) by the cholinesterase inhibitor donepezil and by a 5-HT1A receptor antagonist WAY 100635

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Degeneration of the cholinergic magnocellular neurons in the basal forebrain and their cortical projections is a major feature of the neuropathology of Alzheimer's disease (AD). In addition to memory dysfunction, attentional functions are also impaired in AD.

Objective

We investigated the extent to which the cholinesterase inhibitor donepezil reversed the attentional performance deficit in nucleus basalis magnocellularis (NBM) lesioned rats. We also examined the effects of a selective and potent 5-HT1A receptor antagonist, WAY 100635, on the attentional deficit of NBM lesioned rats.

Methods

We injected α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) into the NBM to selectively destroy cholinergic neurons projecting to the neocortex. Attentional functions were examined using the 5-CSRT task, in which hungry rats were required to locate brief visual targets presented randomly in one of five locations in a specially designed chamber.

Results

AMPA lesions of the NBM caused marked reductions in choline acetyltransferase activity (ChAT) ranging from 30 to 46% in medial areas of the cortex (medial-frontal and cingulate) and from 58 to 72% in more lateral areas (anterior-dorso-lateral and parietal). AMPA lesioned rats made fewer correct responses (choice accuracy), longer latency to correct response and an increase in the number of premature and perseverative responses. These impairments showed some recovery over the next 12 weeks. Reducing the duration of the visual stimulus reinstated the impairments in choice accuracy. The anticholinesterase inhibitor donepezil at 1.0 mg/kg but not 0.5 mg/kg reversed the impairments in choice accuracy and correct response latency. The premature and perseverative over-responding of AMPA lesioned rats remained unchanged. A dose of 0.1 mg/kg WAY 100635 to AMPA-lesioned rats improved their choice accuracy but did not shorten correct response latencies. The number of premature responses was reduced by WAY 100635 but perseverative over-responding was not affected.

Conclusions

The attentional impairments induced due to cortical cholinergic dysfunction may be ameliorated by cholinergic treatments such as cholinesterase inhibitors. In addition, 5-HT1A receptors and the cortical cholinergic system exert balanced opposition in regulating attentional performance in the rat. Blockade of 5-HT1A receptors may be useful to treat some aspects of attentional dysfunction in AD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1A, B.
Fig. 2A, B.
Fig. 3A, B.
Fig. 4A, B.

Similar content being viewed by others

References

  • Andrade R, Nicoll RA (1987) Pharmacologically distinct actions of serotonin on single pyramidal neurones of the rat hippocampus recorded in vitro. J Physiol 394:99–124

    CAS  PubMed  Google Scholar 

  • Araneda R, Andrade R (1991) 5-Hydroxytryptamine2 and 5-hydroxytryptamine 1A receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience 40:399–412

    Google Scholar 

  • Ashby CR Jr, Edwards E, Wang RY (1994) Electrophysiological evidence for a functional interaction between 5-HT1A and 5-HT2A receptors in the rat medial prefrontal cortex: an iontophoretic study. Synapse 17:173–181

    CAS  Google Scholar 

  • Baddeley A, Logie P, Bressi S, Della Sala S, Spinnler H (1986) Dementia and working memory. Q J Exp Psychol 38A:603–618

    Google Scholar 

  • Barnes JM, Barnes NM, Costall B, Naylor RJ, Tyers MB (1989) 5-HT3 receptors mediate inhibition of acetylcholine release in cortical tissue. Nature 338:762–763

    CAS  Google Scholar 

  • Beller SA, Overall JE, Swann AC (1985) Efficacy of oral physostigmine in primary degenerative dementia. A double-blind study of response to different dose level. Psychopharmacology 87:147–151

    CAS  Google Scholar 

  • Bianchi C, Siniscalchi A, Beani L (1990) 5-HT1A agonists increase and 5-HT3 agonists decrease acetylcholine efflux from the cerebral cortex of freely-moving guinea-pigs. Br J Pharmacol 101:448–452

    CAS  PubMed  Google Scholar 

  • Bizot JC, Thiebot MH (1996) Impulsivity as a confounding factor in certain animal tests of cognitive function. Brain Res Cogn Brain Res 3:243–250

    Article  CAS  PubMed  Google Scholar 

  • Bowen DM, Francis PT, Pangalos MN, Stephens PH, Proctor AW, Chessell IP (1992) "Traditional" Pharmacotherapy may succeed in Alzheimer's disease. Trends Neurosci 15:85

    PubMed  Google Scholar 

  • Bowen DM, Francis PT, Chessell IP, Webster M-T (1994) Neurotransmission—the link integrating Alzheimer research ? Trends Neurosci 17:149

    CAS  PubMed  Google Scholar 

  • Cameron I, Curran S, Newton P, Petty D, Wattis J (2000) Use of donepezil for the treatment of mild-moderate Alzheimer's disease: an audit of the assessment and treatment of patients in routine clinical practice. Int J Geriatr Psychiatry 15:887–891

    Article  CAS  PubMed  Google Scholar 

  • Carli M, Samanin R (1992a) 8-Hydroxy-2-(di-n-propylamino) tetralin impairs spatial learning in a water maze: role of postsynaptic 5-HT1A receptors. Br J Pharmacol 105:720–726

    CAS  PubMed  Google Scholar 

  • Carli M, Samanin R (1992b) Serotonin2 receptor agonists and serotonergic anorectic drugs affect rats' performance differently in a five-choice serial reaction time task. Psychopharmacology 106:228–234

    CAS  PubMed  Google Scholar 

  • Carli M, Samanin R (2000) The 5HT1A receptor agonist 8-OH-DPAT reduces rats' accuracy of attentional performance and enhances impulsive responding in a five-choice serial reaction time task: role of presynaptic 5-HT1A receptors. Psychopharmacology 149:259–268

    CAS  PubMed  Google Scholar 

  • Carli M, Robbins TW, Evenden JL, Everitt BJ (1983) Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behav Brain Res 9:361–380

    CAS  PubMed  Google Scholar 

  • Carli M, Luschi R, Samanin R (1995) (S)-WAY 100135, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal scopolamine. Eur J Pharmacol 283:133–139

    Article  CAS  PubMed  Google Scholar 

  • Carli M, Bonalumi P, Samanin R (1997) WAY 100635, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal administration of scopolamine or 7-chloro-kynurenic acid. Brain Res 774:167–174

    CAS  PubMed  Google Scholar 

  • Caudra G, Summers K, Giacobini E (1994) Cholinesterase inhibitor effects on neurotransmitters in rat cortex in vivo. J Pharmacol Exp Ther 270:277–284

    PubMed  Google Scholar 

  • Chalmers DT, Watson SJ (1991) Comparative anatomical distribution of 5-HT1A receptor mRNA and 5-HT1A binding in rat brain—a combined in situ hybridisation/in vitro receptor autoradiographic study. Brain Res 561:51–60

    CAS  PubMed  Google Scholar 

  • Chiba AA, Bucci DJ, Holland PC, Gallagher M (1995) Basal forebrain cholinergic lesions disrupt increments but not decrements in conditioned stimulus processing. J Neurosci 15:7315–7322

    CAS  Google Scholar 

  • Consolo S, Ramponi S, Ladinsky H, Baldi G (1996) A critical role for D1 receptors in the 5-HT1A-mediated facilitation of in vivo acetylcholine release in rat frontal cortex. Brain Res 707:320–323

    CAS  PubMed  Google Scholar 

  • Dalley JW, McGaughy J, O'Connell MT, Cardinal RN, Levita L, Robbins TW (2001) Distinct changes in cortical acetylcholine and noradrenaline efflux during contingent and noncontingent performance of a visual attentional task. J Neurosci 21:4908–4914

    CAS  Google Scholar 

  • Dijk SN, Francis PT, Stratmann GC, Bowen DM (1995) NMDA-induced glutamate and aspartate release from rat cortical pyramidal neurones: evidence for modulation by a 5-HT1A antagonist. Br J Pharmacol 115:1169–1174

    CAS  PubMed  Google Scholar 

  • Dunnett SB, Everitt BJ, Robbins TW (1991) The basal forebrain-cortical cholinergic system: interpreting the functional consequences of excitotoxic lesions. Trends Neurosci 14:494–501

    Google Scholar 

  • Evans M, Ellis A, Watson D, Chowdhury T (2000) Sustained cognitive improvement following treatment of Alzheimer's disease with donepezil. Int J Geriatr Psychiatry 15:50–53

    Article  CAS  Google Scholar 

  • Fletcher A, Forster EA, Bill DJ, Brown G, Cliffe IA, Hartley JE, Jones DE, McLenachan A, Stanhope KJ, Critchley DJ, Childs KJ, Middlefell VC, Lanfumey L, Corradetti R, Laporte AM, Gozlan H, Hamon M, Dourish CT (1996) Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist. Behav Brain Res 73:337–353

    CAS  PubMed  Google Scholar 

  • Fonnum F (1975) A rapid radiochemical method for the determination of choline acetyltransferase. J Neurochem 24:407–409

    CAS  PubMed  Google Scholar 

  • Forster EA, Cliffe IA, Bill DJ, Dover GM, Jones D, Reilly Y, Fletcher A (1995) A pharmacological profile of the selective silent 5-HT1A receptor antagonist WAY-100635. Eur J Pharmacol 281:81–88

    CAS  PubMed  Google Scholar 

  • Francis PT, Palmer AM, Sims NR, Bowen DM, Davidson AN, Esiri MM, Neary D, Snowdon JS, Wilcock GK (1985) Neurochemical studies of early onset Alzheimer's disease: possible influence on treatment. N Engl J Med 313:7–11

    CAS  PubMed  Google Scholar 

  • Francis PT, Pangalos MN, Bowen DM (1992) Animal and drug modelling for Alzheimer synaptic pathology. Prog Neurobiol 39:517–545

    CAS  PubMed  Google Scholar 

  • Francis PT, Cross AJ, Bowen DM (1994) Neurotransmitters and neuropeptides. In: Terry RD, Katzman R, Bick KL (eds) Alzheimer disease. Raven Press, New York, pp 247–261

  • Giacobini E, Zhu X-D, Williams E, Sherman KA (1996) The effect of the selective reversible acetylcholinesterase inhibitor E2020 on extracellular acetylcholine and biogenic amine levels in rat cortex. Neuropharmacology 35:205–211

    Article  CAS  PubMed  Google Scholar 

  • Granon S, Passetti F, Thomas KL, Dalley JW, Everitt BJ, Robbins TW (2000) Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex. J Neurosci 20:1208–1215

    PubMed  Google Scholar 

  • Harder JA, Maclean CJ, Alder JT, Francis PT, Ridley RM (1996) The 5-HT1A antagonist, WAY 100635, ameliorates the cognitive impairment induced by fornix transection in the marmoset. Psychopharmacology 127:245–254

    Article  CAS  PubMed  Google Scholar 

  • Harrison AA, Everitt BJ, Robbins TW (1997) Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms. Psychopharmacology 133:329–342

    CAS  PubMed  Google Scholar 

  • Himmelheber AM, Sarter M, Bruno JP (1997) Operant performance and cortical acetylcholine release: role of response rate, reward density, and non-contingent stimuli. Brain Res Cognit Brain Res 6:23–36

    Article  CAS  Google Scholar 

  • Himmelheber AM, Sarter M, Bruno JP (2001) The effects of manipulations of attentional demand on cortical acetylcholine release. Brain Res Cognit Brain Res 12:353–370

    Article  CAS  Google Scholar 

  • Khateb A, Fort P, Alonso A, Jones BE, Mühlethaler M (1993) Pharmacological and immunohistochemical evidence for serotonergic modulation of cholinergic nucleus basalis neurons. Eur J Neurosci 5:541–547

    CAS  Google Scholar 

  • Kia HK, Brisorgueil MJ, Daval G, Langlois X, Hamon M, Verge D (1996a) Serotonin1A receptors are expressed by a subpopulation of cholinergic neurons in the rat medial septum and diagonal band of Broca—a double immunocytochemical study. Neuroscience 74:143–154

    Article  CAS  PubMed  Google Scholar 

  • Kia HK, Miquel MC, Brisorgueil MJ, Daval G, Riad M, El Mestikawy S, Hamon M, Verge D (1996b) Immunocytochemical localization of serotonin1A receptors in the rat central nervous system. J Comp Neurol 365:289–305

    CAS  PubMed  Google Scholar 

  • Kosasa T, Kuriya Y, Yamanishi Y (1999) Effect of donepezil hydrochloride (E2020) on extracellular acetylcholine concentration in the cerebral cortex of rats. Jpn J Pharmacol 81:216–222

    Article  CAS  PubMed  Google Scholar 

  • Kosasa T, Kuriya Y, Matsui K, Yamanishi Y (2000) Inhibitory effect of orally administered donepezil hydrochloride (E2020), a novel treatment for Alzheimer's disease, on cholinesterase activity in rats. Eur J Pharmacol 389:173–179

    Article  CAS  Google Scholar 

  • Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ (1951) Protein measurement with folin phenol reagent. J Biol Chem 193:265–275

    CAS  Google Scholar 

  • Marston HM, West HL, Wilkinson LS, Everitt BJ, Robbins TW (1994) Effects of excitotoxic lesions of the septum and vertical limb nucleus of the diagonal band of Broca on conditional visual discrimination: relationship between performance and choline acetyltransferase activity in the cingulate cortex. J Neurosci 14:2009–2019

    CAS  PubMed  Google Scholar 

  • McGaughy J, Kaiser T, Sarter M (1996) Behavioural vigilance following infusions of 192 IgG-saporin into the basal forebrain: selectivity of the behavioural impairment and relation to cortical AChE-positive fiber density. Behav Neurosci 110:247–256

    CAS  PubMed  Google Scholar 

  • McGaughy J, Dalley JW, Morrison CH, Everitt BJ, Robbins TW (2002) Selective behavioral and neurochemical effects of cholinergic lesions produced by intrabasalis infusions of 192 IgG-saporin on attentional performance in a five-choice serial reaction time task. J Neurosci 22:1905–1913

    CAS  PubMed  Google Scholar 

  • Muir JL, Robbins TW, Everitt BJ (1992) Disruptive effects of muscimol infused into the basal forebrain on conditional discrimination and visual attention: differential interactions with cholinergic mechanisms. Psychopharmacology 107:541–550

    CAS  PubMed  Google Scholar 

  • Muir JL, Everitt BJ, Robbins TW (1994) AMPA-induced excitotoxic lesions of the basal forebrain: a significant role for the cortical cholinergic system in attentional function. J Neurosci 14:2313–2326

    CAS  PubMed  Google Scholar 

  • Muir JL, Everitt BJ, Robbins TW (1995) Reversal of visual attentional dysfunction following lesions of the cholinergic basal forebrain by physostigmine and nicotine but not by the 5-HT3 receptor antagonist, ondansetron. Psychopharmacology:82–92

  • Muir JL, Bussey TJ, Everitt BJ, Robbins TW (1996) Dissociable effects of AMPA-induced lesions of the vertical limb diagonal band of Broca on performance of the 5-choice serial reaction time task and on acquisition of a conditional visual discrimination. Behav Brain Res 82:31–44

    CAS  PubMed  Google Scholar 

  • Ogura H, Kosasa T, Kuriya Y, Yamanishi Y (2000) Donepezil, a centrally acting acetylcholinesterase inhibitor, alleviates learning deficits in hypocholinergic models in rats. Methods Find Exp Clin Pharmacol 22:89–95

    CAS  Google Scholar 

  • Page KJ, Everitt BJ, Robbins TW, Marston HM, Wilkinson LS (1991) Dissociable effects on spatial maze and passive avoidance acquisition and retention following AMPA- and ibotenic acid-induced excitotoxic lesions of the basal forebrain in rats: differential dependence on cholinergic neuronal loss. Neuroscience 43:457–72

    CAS  PubMed  Google Scholar 

  • Passetti F, Dalley JW, O'Connel MT, Everitt BJ, Robbins TW (2000) Increased acetylcholine release in the rat medial prefrontal cortex during performance of a visual attentional task. Eur J Neurosci 12:3051–3058

    CAS  PubMed  Google Scholar 

  • Perry EK, Tomlinson BE, Blessed G, Bergman K, Gibson PH, Perry RH (1978) Correlations of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. BMJ 2:1457–1459

    CAS  PubMed  Google Scholar 

  • Pompeiano M, Palacios JM, Mengod G (1992) Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding. J Neurosci 12:440–453

    CAS  PubMed  Google Scholar 

  • Robbins TW, Everitt BJ, Ryan CN, Marston HM, Jones GH, Page KJ (1989) Comparative effects of quisqualic and ibotenic acid-induced lesions of the substantia innominata and globus pallidus on the acquisition of a conditional visual discrimination: differential effects on cholinergic mechanisms. Neuroscience 28:337–352

    Google Scholar 

  • Robbins TW, Granon S, Muir JL, Durantou F, Harrison A, Everitt BJ (1998) Neural systems underlying arousal and attention. Ann NY Acad Sci 846:222–237

    CAS  PubMed  Google Scholar 

  • Rogers SL, Friedhoff LT (1996) The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group. Dementia 7:293–303

    CAS  PubMed  Google Scholar 

  • Rogers SL, Friedhoff LT (1998) Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study. Eur Neuropsychopharmacol 8:67–75

    Google Scholar 

  • Rogers SL, Yamanishi Y, Yamatsu K (1991) E2020: the pharmacology of a piperidine cholinesterase inhibitor. In: Becker R, Giacobini E (eds) Cholinergic basis for Alzheimer therapy. Birkhauser, Boston, MA, pp 314–320

  • Rogers SL, Doody RS, Mohs RC, Friedhoff LT (1998) Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group. Arch Int Med 158:1021–1031

    CAS  Google Scholar 

  • Sahakian BJ, Owen AM, Morant NJ, Eagger SA, Boddington S, Crayton L, Crockford HA, Crooks M, Hill K, Levy R (1993) Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB. Psychopharmacology 110:395–401

    CAS  PubMed  Google Scholar 

  • Sherman KA (1991) Pharmacodynamics of oral E2020 and tacrine in humans: novel approaches. In: Becker R, Giacobini E (eds) Cholinergic basis for Alzheimer therapy. Birkhauser, Boston, MA, pp 321–328

  • Shinotoh H, Aotsuka A, Fukushi K, Nagatsuka S, Tanaka N, Ota T, Tanada S, Irie T (2001) Effect of donepezil on brain acetylcholinesterase activity in patients with AD measured by PET. Neurology 56:408–410

    CAS  PubMed  Google Scholar 

  • Snape MF, Misra A, Murray TK, De Souza RJ, Williams JL, Cross AJ, Green AR (1999) A comparative study in rats of the in vitro and in vivo pharmacology of the acetylcholinesterase inhibitors tacrine, donepezil and NXX-066. Neuropharmacology 38:181–193

    Article  CAS  PubMed  Google Scholar 

  • Summers WK, Majovski LV, Marsh GM, Tachiki K, Kling A (1986) Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. N Engl J Med 315:1241–1245

    CAS  PubMed  Google Scholar 

  • Tiraboschi P, Hansen LA, Alford M, Masliah E, Thal LJ, Corey-Bloom J (2000) The decline in synapses and cholinergic activity is asynchronous in Alzheimer's disease. Neurology 55:1278–1283

    CAS  PubMed  Google Scholar 

  • Turchi J, Sarter M (1997) Cortical acetylcholine and processing capacity: effects of cortical cholinergic deafferentation on crossmodal divided attention in rats. Brain Res Cognit Brain Res 6:147–158

    Article  CAS  Google Scholar 

  • Voytko ML (1996) Cognitive functions of the basal forebrain cholinergic system in monkeys: memory or attention? Behav Brain Res 75:13–25

    Article  CAS  PubMed  Google Scholar 

  • Voytko ML, Olton DS, Richardson RT, Gorman LK, Tobin JR, Price DL (1994) Basal forebrain lesions in monkeys disrupt attention but not learning and memory. J Neurosci 14:167–186

    Google Scholar 

  • Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, DeLong MR (1982) Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 215:1237–1239

    CAS  PubMed  Google Scholar 

  • Winer BJ (1971) Statistical principles in experimental design, 2nd edn. McGraw-Hill, New York

  • Zilles K, Werner L, Qu M, Schleicher A, Gross G (1991) Quantitative autoradiography of 11 different transmitter binding sites in the basal forebrain region of the rat—evidence of heterogeneity in distribution patterns. Neuroscience 42:473–481

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We are grateful to Dr. E Grossi of the Bracco (Italy) for the generous gift of donepezil and for a travel grant to Claudia Balducci allowing her to present this data at the Neuroscience Meeting held in San Diego, 2001.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Carli.

Additional information

Dr. Rosario Samanin died on 5 June 2001

Rights and permissions

Reprints and permissions

About this article

Cite this article

Balducci, C., Nurra, M., Pietropoli, A. et al. Reversal of visual attention dysfunction after AMPA lesions of the nucleus basalis magnocellularis (NBM) by the cholinesterase inhibitor donepezil and by a 5-HT1A receptor antagonist WAY 100635. Psychopharmacology 167, 28–36 (2003). https://doi.org/10.1007/s00213-002-1385-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-002-1385-7

Keywords

Navigation